Ajax

Developer of targeted therapies for the treatment of hematologic malignancies

placeCambridge, Massachusetts, United States calendar_todayFounded 2019 language ajaxtherapeutics.com

Social engagement

Social engagement: 2.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include EcoR1, Goldman Sachs Asset Management.

Investor typeCountShare
Venture capital220%
Private equity110%
Other / undisclosed770%

Recent activity

10 Dec 2025
Milestone
regulatory
23 Oct 2025
Leadership hire
scientific founder and Board member
Coming soon